 Shares of Spirit Aerosystems have rallied by over 110 since November 2020 when Pfizer reported a high efficacy rate of its vaccine and the FAA lifted its ban on MAX aircraft. Investor optimism towards the company that manufactures fuselage, propulsion, and wings for Boeing and Airbus drove this. 